CN204813901U - A smart machine for monitoring of cancer recurring real time kinematic - Google Patents
A smart machine for monitoring of cancer recurring real time kinematic Download PDFInfo
- Publication number
- CN204813901U CN204813901U CN201520501151.5U CN201520501151U CN204813901U CN 204813901 U CN204813901 U CN 204813901U CN 201520501151 U CN201520501151 U CN 201520501151U CN 204813901 U CN204813901 U CN 204813901U
- Authority
- CN
- China
- Prior art keywords
- albumen
- module
- controller
- wireless communication
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
Abstract
The utility model discloses a smart machine for monitoring of cancer recurring real time kinematic, this smart machine include internal implantation subassembly and external subassembly, and internal implantation subassembly is responsible for changing the mark of the cancer in the blood - albumen concentration information the digital information of transmissible into, and external subassembly is responsible for showing the alarm that erupts simultaneously out with received digital information, reminds the cancer recurring probably to take place. The utility model discloses a smart machine can the real -time supervision cancer the recurring condition, make the patient of cancer recurring can obtain timely treatment.
Description
Technical field
This utility model belongs to medical instruments field, relates to a kind of smart machine, is specifically related to a kind of smart machine for cancer return real-time dynamic monitoring.
Background technology
The curative competence of current China cancer is also not fully up to expectations, and in whole cancer patient, nearly 1/3 can be cured, and obtains the chance of long term survival, but also has the cancer patient about half to occur relapse and metastasis in the course of disease.Cancer return refers to that the cancer be brought under control occurs again on former hair device official, or cancer invades lymph vessels or body cavity from original site, moves to elsewhere continued growth, forms the tumor with primary tumor same-type.Some cancer can first treatment after some months or recur after several years.Therefore for cancer patient, the monitoring carrying out postoperative recurrence transfer is very important.The sign of cancer return transfer find more early, just can take counter-measure in time, the probability that effective suppression cancer return shifts, the life cycle that prolongation cancer patient is postoperative.
The mode of current patient monitoring cancer return mainly regularly arrives hospital and checks, and this mode is for patient, and one is inconvenient, and expend time in, two is check not in time, likely misses the probability of early discovery cancer return.Conveniently cancer patient can check oneself the recurrence of cancer timely, study a kind of can Real-Time Monitoring cancer patient recurrence equipment be necessary.
Summary of the invention
In order to solve the deficiencies in the prior art, the purpose of this utility model is to provide a kind of smart machine for cancer return real-time dynamic monitoring, and described smart machine completes the monitoring to cancer return by the level of oncoprotein matter in monitoring of blood.Described smart machine arranges the threshold value of the level of oncoprotein matter in a blood, when detecting that the level of oncoprotein matter in blood reaches or exceedes this threshold value, described smart machine then can notify by the mode given the alarm that monitoring system wearer cancer return may occur, cancer patient just can arrive hospital in time and make a definite diagnosis, and enables the state of an illness obtain control early.
To achieve these goals, this utility model takes following technical scheme:
For a smart machine for cancer return real-time dynamic monitoring, described smart machine comprises et al. Ke assembly 1 and external assembly 2; Described et al. Ke assembly 1 comprises blood protein sensor 11, data processing module 12, first wireless communication module 13; Described blood protein sensor 11 comprises albumen trapping layer 111, binding signal inductive layer 112, heating module 113, refrigeration module 114, containment vessel 115; Described albumen trapping layer 111 sticks on binding signal inductive layer 112, described containment vessel 115 covers in described albumen trapping layer 111 for described albumen trapping layer 111 being opened with blood separating, described heating module 113 for by the transient heating of described albumen sensor 11 to more than 56 DEG C, described refrigeration module 114 is for being reduced to physiological temp instantaneously by the temperature of the described albumen sensor 11 heated; Described data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124; Described input interface 121 receives the electrochemical signals of described blood protein sensor 11 output and inputs described microprocessor 122 after it is converted into digital signal, is uploaded to described external assembly 2 after described microprocessor 122 pairs of digital signals carry out protocol conversion by described output interface 123 via described first wireless communication module 13; Described external assembly 2 comprises data receiver 21, and described data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214; Described controller 211 receives and analyzes the protein signal that described et al. Ke assembly 1 uploads, afterwards Protein Information is sent on display 212 and shows, the analysis programme of described controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of albumen, described controller 211 sends instruction to described siren 213, described siren 213 gives the alarm, and notifies that wearer notes the danger of cancer return; The control command of described controller 211 passes on the described reactor 124 in described et al. Ke assembly 1 by described second wireless communication module 214, and described reactor 124 controls the unlatching of described containment vessel 115 or closedown, the startup of control heating module 113 or dormancy, the startup of control refrigeration module 114 or dormancy.
Further, described external assembly 2 also comprises intelligent mobile terminal equipment 22, described data receiver 21 also comprises the 3rd wireless communication module 215, and tumor marker protein information is sent in described intelligent mobile terminal equipment 22 by described 3rd wireless communication module 215 by described controller 211.
Described intelligent mobile terminal equipment 22 can be smart mobile phone, flat board or computer.
Further, described siren 213 is vibrators, notifies that wearer notes the danger of cancer return by the mode of vibration.
Further, described siren 213 is luminous organs, notifies that wearer notes the danger of cancer return by the mode of luminescence.
Further, described albumen trapping layer 111 is made up of the antibody with blood protein specific binding.
Further, described binding signal inductive layer 112 is made up of array of nanowire transistors.
The combination of described albumen trapping layer 111 of the present utility model and described binding signal inductive layer 112 is the antibody surface of nano-wire transistor being covered with one deck target protein.
The operation principle of described blood protein sensor 11 of the present utility model is: when after the antibodies on the tumor markers-target protein in blood and described albumen trapping layer 111, with the electron interaction of the nano-wire transistor top layer movement on described binding signal inductive layer 112, change the electric conductivity of nano-wire transistor, before and after being combined by comparison target protein, the difference of the electric conductivity of nano-wire transistor, can know the concentration information of target protein in blood.
The kind of the antibody in this utility model albumen trapping layer 111 determines according to the target protein of antibody capture.The target protein satisfied condition is the mark of cancer return and transfer, and the concentration namely by detecting target protein can judge whether cancer recurs or again shift.The antibody that the marker protein of every cancer return and transfer is corresponding all can be used for this utility model.
Further, described first wireless communication module 13, described second wireless communication module 214, described 3rd wireless communication module 215 adopt any one in Bluetooth protocol or Zigbee protocol.
Further, described data receiver 12 can be worn at any part on cancer patient's health, is preferably worn in wrist.In addition, described data receiver 12 also can not be worn on a certain position of health of cancer patient, but uses as in vitro accessory.
Further, the timing of described controller 211 realize the control to the unlatching of described containment vessel 115 or closedown, the startup to heating module 113 or dormancy control, to the startup of refrigeration module 114 or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
The operational approach of the smart machine for cancer return real-time dynamic monitoring of the present utility model:
(1) described et al. Ke assembly 1 is implanted in blood;
(2) issue an order to described reactor 124 by described controller 211 and make it to control the unlatching of described containment vessel 115, at this moment described albumen trapping layer 111 and contacting blood, target protein and antibodies;
(3) after reacting certain hour, issue an order to described reactor 124 to make it to control described heating module 113 by described controller 211 and start, described albumen trapping layer 111 and described binding signal inductive layer 112 transient temperature is caused to reach 56 DEG C, now, the antigen combined is separated with antibody, afterwards, described controller 211 issues an order to described reactor 124 to control described containment vessel 115 and cuts out, described albumen trapping layer 111 is isolated with blood, simultaneously described controller 211 is issued an order to described reactor 124 to control refrigeration module 114 and the temperature of described albumen trapping layer 111 and described binding signal inductive layer 112 is reduced to physiological temp, thus complete one-time detection.
(4) wearer of smart machine of the present utility model is known by the information and the reaction of siren 213 of observing the display of described display 212 and whether be there occurs cancer return danger;
Described heating module 113 causes described albumen trapping layer 111 and described binding signal inductive layer 112 to be elevated to more than 56 DEG C, this process is instantaneous, and after heating the only extremely short time namely start described refrigeration module 114 and complete temperature-fall period, therefore in whole process to the composition in blood without any injurious effects.
Preferably, described heating module 113 causes described albumen trapping layer 111 and described binding signal inductive layer 112 to be elevated to 56 DEG C.Because under 56 DEG C of conditions, the antigen-antibody that combined is separated, more than the 56 DEG C separation that can realize conjugated antigen antibody too.
Advantage of the present utility model and beneficial effect:
By the level detecting the tumor marker protein in blood, whether the smart machine that 1, this utility model is used for cancer return real-time dynamic monitoring judges that cancer patient is postoperative and recurs, the diagnosis of molecular level can be able to find in early days in recurrence, provides diagnostic base for taking corresponding treatment means effectively and timely.
2, the smart machine for cancer return real-time dynamic monitoring of the present utility model can realize monitoring anywhere or anytime, reaches the object of real-time dynamic monitoring, and cancer patient can be made to grasp the current intelligence of cancer return transfer easily timely.
3, the smart machine for cancer return real-time dynamic monitoring of the present utility model can reuse, this smart machine reaches the object of antigen-antibody coalition separation by the temperature controlling blood protein sensor, avoids the operation often detecting and once need again to implant smart machine afterwards.
Accompanying drawing explanation
Fig. 1 shows a kind of structural representation of the smart machine for cancer return real-time dynamic monitoring of the present utility model;
Fig. 2 shows a kind of structural representation of the smart machine for cancer return real-time dynamic monitoring of the present utility model;
Wherein, 1: et al. Ke assembly; 11: blood protein sensor; 111: albumen trapping layer, 112: binding signal inductive layer; 113: heating module; 114: refrigeration module; 115: containment vessel; 12: data processing module; 121: input interface, 122: microprocessor, 123: output interface; 124: reactor; 13: the first wireless communication modules; 2: external assembly; 21: data receiver; 211: controller; 212: display; 213: siren; 214: the second wireless communication modules; 215: the three wireless communication modules; 22: intelligent mobile terminal equipment.
Detailed description of the invention
Below in conjunction with specific embodiment, illustrate this utility model further.Should be understood that these embodiments are only not used in restriction scope of the present utility model for illustration of this utility model.
Embodiment 1 one kinds of smart machines for cancer return real-time dynamic monitoring
For a smart machine for cancer return real-time dynamic monitoring, smart machine comprises et al. Ke assembly 1 and external assembly 2; Et al. Ke assembly 1 comprises blood protein sensor 11, data processing module 12, first wireless communication module 13; Blood protein sensor 11 comprises albumen trapping layer 111, binding signal inductive layer 112, heating module 113, refrigeration module 114, containment vessel 115; Albumen trapping layer 111 sticks on binding signal inductive layer 112, containment vessel 115 covers in albumen trapping layer 111 for albumen trapping layer 111 and blood separating being opened, heating module 113 for by albumen sensor 11 transient heating to more than 56 DEG C, refrigeration module 114 is for being reduced to physiological temp instantaneously by the temperature of the albumen heated sensor 11; Data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124; Input interface 121 receives the electrochemical signals input microprocessor 122 after it being converted into digital signal that blood protein sensor 11 exports, and is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13; External assembly 2 comprises data receiver 21, and data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214; Controller 211 receives and analyzing body is implanted into the protein signal that assembly 1 is uploaded, afterwards Protein Information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of albumen, controller 211 sends instruction to siren 213, siren 213 gives the alarm, and notifies that wearer notes the danger of cancer return; The control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, the startup of the startup of the unlatching of reactor 124 Control protection shell 115 or closedown, control heating module 113 or dormancy, control refrigeration module 114 or dormancy.
Siren 213 is vibrators, notifies that wearer notes the danger of cancer return by the mode of vibration.
Albumen trapping layer 111 is made up of the antibody with blood protein specific binding.
Binding signal inductive layer 112 is made up of array of nanowire transistors.
The combination of albumen trapping layer 111 and binding signal inductive layer 112 is the antibody surface of nano-wire transistor being covered with one deck target protein.
The operation principle of blood protein sensor 11 is: when after the tumor markers-target protein in blood and the antibodies in albumen trapping layer 111, with the electron interaction of the nano-wire transistor top layer movement on binding signal inductive layer 112, change the electric conductivity of nano-wire transistor, before and after being combined by comparison target protein, the difference of the electric conductivity of nano-wire transistor, can know the concentration information of target protein in blood.
First wireless communication module 13, second wireless communication module 214 adopts Bluetooth protocol.
Data receiver 12 can be worn at any part on cancer patient's health, such as, be worn in wrist.
Controller 211 timing realize the control to the unlatching of described containment vessel 115 or closedown, the startup to heating module 113 or dormancy control, to the startup of refrigeration module 114 or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Heating module 113 causes albumen trapping layer 111 and binding signal inductive layer 112 to be elevated to more than 56 DEG C, this process is instantaneous, and after heating the only extremely short time namely start refrigeration module 114 and complete temperature-fall period, therefore in whole process to the composition in blood without any adverse influence.
Operational approach for the smart machine of cancer return real-time dynamic monitoring:
(1) et al. Ke assembly 1 is implanted in blood;
(2) issue an order to reactor 124 by controller 211 and make it the unlatching of Control protection shell 115, at this moment albumen trapping layer 111 and contacting blood, target protein and antibodies;
(3) after reacting certain hour, issue an order to reactor 124 to make it to control heating module 113 by controller 211 and start, albumen trapping layer 111 and binding signal inductive layer 112 transient temperature is caused to reach 56 DEG C, now, the antigen combined is separated with antibody, afterwards, controller 211 cuts out to reactor 124 Control protection shell 115 of issuing an order, albumen trapping layer 111 and blood are isolated, issue an order to reactor 124 to control refrigeration module 114 with Time Controller 211 and the temperature of albumen trapping layer 111 and binding signal inductive layer 112 is reduced to physiological temp, thus complete one-time detection,
(4) reaction of the information that shown by observation display 212 of the wearer of this smart machine and siren 213 is known and whether be there occurs cancer return danger.
Embodiment 2 one kinds of smart machines for cancer return real-time dynamic monitoring
For a smart machine for cancer return real-time dynamic monitoring, smart machine comprises et al. Ke assembly 1 and external assembly 2; Et al. Ke assembly 1 comprises blood protein sensor 11, data processing module 12, first wireless communication module 13; Blood protein sensor 11 comprises albumen trapping layer 111, binding signal inductive layer 112, heating module 113, refrigeration module 114, containment vessel 115; Albumen trapping layer 111 sticks on binding signal inductive layer 112, containment vessel 115 covers in albumen trapping layer 111 for albumen trapping layer 111 and blood separating being opened, heating module 113 for by albumen sensor 11 transient heating to more than 56 DEG C, refrigeration module 114 is for being reduced to physiological temp instantaneously by the temperature of the albumen heated sensor 11; Data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124; Input interface 121 receives the electrochemical signals input microprocessor 122 after it being converted into digital signal that blood protein sensor 11 exports, and is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13; External assembly 2 comprises data receiver 21, and data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214; Controller 211 receives and analyzing body is implanted into the protein signal that assembly 1 is uploaded, afterwards Protein Information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of albumen, controller 211 sends instruction to siren 213, siren 213 gives the alarm, and notifies that wearer notes the danger of cancer return; The control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, the startup of the startup of the unlatching of reactor 124 Control protection shell 115 or closedown, control heating module 113 or dormancy, control refrigeration module 114 or dormancy.
Siren 213 is luminous organs, notifies that wearer notes the danger of cancer return by the mode of luminescence.
Albumen trapping layer 111 is made up of the antibody with blood protein specific binding.
Binding signal inductive layer 112 is made up of array of nanowire transistors.
The combination of albumen trapping layer 111 and binding signal inductive layer 112 is the antibody surface of nano-wire transistor being covered with one deck target protein.
The operation principle of blood protein sensor 11 is: when after the tumor markers-target protein in blood and the antibodies in albumen trapping layer 111, with the electron interaction of the nano-wire transistor top layer movement on binding signal inductive layer 112, change the electric conductivity of nano-wire transistor, before and after being combined by comparison target protein, the difference of the electric conductivity of nano-wire transistor, can know the concentration information of target protein in blood.
First wireless communication module 13, second wireless communication module 214 adopts Zigbee protocol.
Data receiver 12 uses as in vitro accessory.
Controller 211 timing realize the control to the unlatching of described containment vessel 115 or closedown, the startup to heating module 113 or dormancy control, to the startup of refrigeration module 114 or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Heating module 113 causes albumen trapping layer 111 and binding signal inductive layer 112 to be elevated to more than 56 DEG C, this process is instantaneous, and after heating the only extremely short time namely start refrigeration module 114 and complete temperature-fall period, therefore in whole process to the composition in blood without any adverse influence.
Operational approach for the smart machine of cancer return real-time dynamic monitoring:
(1) et al. Ke assembly 1 is implanted in blood;
(2) issue an order to reactor 124 by controller 211 and make it the unlatching of Control protection shell 115, at this moment albumen trapping layer 111 and contacting blood, target protein and antibodies;
(3) after reacting certain hour, issue an order to reactor 124 to make it to control heating module 113 by controller 211 and start, albumen trapping layer 111 and binding signal inductive layer 112 transient temperature is caused to reach 56 DEG C, now, the antigen combined is separated with antibody, afterwards, controller 211 cuts out to reactor 124 Control protection shell 115 of issuing an order, albumen trapping layer 111 and blood are isolated, issue an order to reactor 124 to control refrigeration module 114 with Time Controller 211 and the temperature of albumen trapping layer 111 and binding signal inductive layer 112 is reduced to physiological temp, thus complete one-time detection,
(4) reaction of the information that shown by observation display 212 of the wearer of this smart machine and siren 213 is known and whether be there occurs cancer return danger.
Embodiment 3 one kinds of smart machines for cancer return real-time dynamic monitoring
For a smart machine for cancer return real-time dynamic monitoring, smart machine comprises et al. Ke assembly 1 and external assembly 2; Et al. Ke assembly 1 comprises blood protein sensor 11, data processing module 12, first wireless communication module 13; Blood protein sensor 11 comprises albumen trapping layer 111, binding signal inductive layer 112, heating module 113, refrigeration module 114, containment vessel 115; Albumen trapping layer 111 sticks on binding signal inductive layer 112, containment vessel 115 covers in albumen trapping layer 111 for albumen trapping layer 111 and blood separating being opened, heating module 113 for by albumen sensor 11 transient heating to more than 56 DEG C, refrigeration module 114 is for being reduced to physiological temp instantaneously by the temperature of the albumen heated sensor 11; Data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124; Input interface 121 receives the electrochemical signals input microprocessor 122 after it being converted into digital signal that blood protein sensor 11 exports, and is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13; External assembly 2 comprises data receiver 21, and data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214; Controller 211 receives and analyzing body is implanted into the protein signal that assembly 1 is uploaded, afterwards Protein Information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of albumen, controller 211 sends instruction to siren 213, siren 213 gives the alarm, and notifies that wearer notes the danger of cancer return; The control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, the startup of the startup of the unlatching of reactor 124 Control protection shell 115 or closedown, control heating module 113 or dormancy, control refrigeration module 114 or dormancy.
External assembly 2 also comprises intelligent mobile terminal equipment 22, and data receiver 21 also comprises the 3rd wireless communication module 215, and tumor marker protein information is sent in intelligent mobile terminal equipment 22 by the 3rd wireless communication module 215 by controller 211.Intelligent mobile terminal equipment 22 pairs of Protein Information carry out remote storage and analysis.
Intelligent mobile terminal equipment 22 can be smart mobile phone, flat board or computer.
Data receiver 12 can be worn on any part of cancer patient's health, such as wrist.
First wireless communication module 13, second wireless communication module 214, the 3rd wireless communication module 215 adopt Bluetooth protocol.
Siren 213 is vibrators, notifies that wearer notes the danger of cancer return by the mode of vibration.
Albumen trapping layer 111 is made up of the antibody with blood protein specific binding.
Binding signal inductive layer 112 is made up of array of nanowire transistors.
The combination of albumen trapping layer 111 and binding signal inductive layer 112 is the antibody surface of nano-wire transistor being covered with one deck target protein.
The operation principle of blood protein sensor 11 is: when after the tumor markers-target protein in blood and the antibodies in albumen trapping layer 111, with the electron interaction of the nano-wire transistor top layer movement on binding signal inductive layer 112, change the electric conductivity of nano-wire transistor, before and after being combined by comparison target protein, the difference of the electric conductivity of nano-wire transistor, can know the concentration information of target protein in blood.
Controller 211 timing realize the control to the unlatching of described containment vessel 115 or closedown, the startup to heating module 113 or dormancy control, to the startup of refrigeration module 114 or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Heating module 113 causes albumen trapping layer 111 and binding signal inductive layer 112 to be elevated to more than 56 DEG C, this process is instantaneous, and after heating the only extremely short time namely start refrigeration module 114 and complete temperature-fall period, therefore in whole process to the composition in blood without any adverse influence.
Operational approach for the smart machine of cancer return real-time dynamic monitoring:
(1) et al. Ke assembly 1 is implanted in blood;
(2) issue an order to reactor 124 by controller 211 and make it the unlatching of Control protection shell 115, at this moment albumen trapping layer 111 and contacting blood, target protein and antibodies;
(3) after reacting certain hour, issue an order to reactor 124 to make it to control heating module 113 by controller 211 and start, albumen trapping layer 111 and binding signal inductive layer 112 transient temperature is caused to reach 56 DEG C, now, the antigen combined is separated with antibody, afterwards, controller 211 cuts out to reactor 124 Control protection shell 115 of issuing an order, albumen trapping layer 111 and blood are isolated, issue an order to reactor 124 to control refrigeration module 114 with Time Controller 211 and the temperature of albumen trapping layer 111 and binding signal inductive layer 112 is reduced to physiological temp, thus complete one-time detection,
(4) reaction of the information that shown by observation display 212 or intelligent terminal 22 of the wearer of this smart machine and siren 213 is known and whether be there occurs cancer return danger.
Embodiment 4 one kinds of smart machines for cancer return real-time dynamic monitoring
For a smart machine for cancer return real-time dynamic monitoring, smart machine comprises et al. Ke assembly 1 and external assembly 2; Et al. Ke assembly 1 comprises blood protein sensor 11, data processing module 12, first wireless communication module 13; Blood protein sensor 11 comprises albumen trapping layer 111, binding signal inductive layer 112, heating module 113, refrigeration module 114, containment vessel 115; Albumen trapping layer 111 sticks on binding signal inductive layer 112, containment vessel 115 covers in albumen trapping layer 111 for albumen trapping layer 111 and blood separating being opened, heating module 113 for by albumen sensor 11 transient heating to more than 56 DEG C, refrigeration module 114 is for being reduced to physiological temp instantaneously by the temperature of the albumen heated sensor 11; Data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124; Input interface 121 receives the electrochemical signals input microprocessor 122 after it being converted into digital signal that blood protein sensor 11 exports, and is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13; External assembly 2 comprises data receiver 21, and data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214; Controller 211 receives and analyzing body is implanted into the protein signal that assembly 1 is uploaded, afterwards Protein Information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of albumen, controller 211 sends instruction to siren 213, siren 213 gives the alarm, and notifies that wearer notes the danger of cancer return; The control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, the startup of the startup of the unlatching of reactor 124 Control protection shell 115 or closedown, control heating module 113 or dormancy, control refrigeration module 114 or dormancy.
External assembly 2 also comprises intelligent mobile terminal equipment 22, and data receiver 21 also comprises the 3rd wireless communication module 215, and tumor marker protein information is sent in intelligent mobile terminal equipment 22 by the 3rd wireless communication module 215 by controller 211.Intelligent mobile terminal equipment 22 pairs of Protein Information carry out remote storage and analysis.
Intelligent mobile terminal equipment 22 can be smart mobile phone, flat board or computer.
Data receiver 12 uses as in vitro accessory.
First wireless communication module 13, second wireless communication module 214, the 3rd wireless communication module 215 adopt Zigbee protocol.
Siren 213 is luminous organs, notifies that wearer notes the danger of cancer return by the mode of luminescence.
Albumen trapping layer 111 is made up of the antibody with blood protein specific binding.
Binding signal inductive layer 112 is made up of array of nanowire transistors.
The combination of albumen trapping layer 111 and binding signal inductive layer 112 is the antibody surface of nano-wire transistor being covered with one deck target protein.
The operation principle of blood protein sensor 11 is: when after the tumor markers-target protein in blood and the antibodies in albumen trapping layer 111, with the electron interaction of the nano-wire transistor top layer movement on binding signal inductive layer 112, change the electric conductivity of nano-wire transistor, before and after being combined by comparison target protein, the difference of the electric conductivity of nano-wire transistor, can know the concentration information of target protein in blood.
Controller 211 timing realize the control to the unlatching of described containment vessel 115 or closedown, the startup to heating module 113 or dormancy control, to the startup of refrigeration module 114 or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Heating module 113 causes albumen trapping layer 111 and binding signal inductive layer 112 to be elevated to more than 56 DEG C, this process is instantaneous, and after heating the only extremely short time namely start refrigeration module 114 and complete temperature-fall period, therefore in whole process to the composition in blood without any adverse influence.
Operational approach for the smart machine of cancer return real-time dynamic monitoring:
(1) et al. Ke assembly 1 is implanted in blood;
(2) issue an order to reactor 124 by controller 211 and make it the unlatching of Control protection shell 115, at this moment albumen trapping layer 111 and contacting blood, target protein and antibodies;
(3) after reacting certain hour, issue an order to reactor 124 to make it to control heating module 113 by controller 211 and start, albumen trapping layer 111 and binding signal inductive layer 112 transient temperature is caused to reach 56 DEG C, now, the antigen combined is separated with antibody, afterwards, controller 211 cuts out to reactor 124 Control protection shell 115 of issuing an order, albumen trapping layer 111 and blood are isolated, issue an order to reactor 124 to control refrigeration module 114 with Time Controller 211 and the temperature of albumen trapping layer 111 and binding signal inductive layer 112 is reduced to physiological temp, thus complete one-time detection,
(4) reaction of the information that shown by observation display 212 of the wearer of this smart machine and siren 213 is known and whether be there occurs cancer return danger.
Although illustrate and described embodiment of the present utility model, those having ordinary skill in the art will appreciate that: can carry out multiple change, amendment, replacement and modification to these embodiments when not departing from principle of the present utility model and aim, scope of the present utility model is by claim and equivalents thereof.
Claims (2)
1. for a smart machine for cancer return real-time dynamic monitoring, it is characterized in that, described smart machine comprises et al. Ke assembly (1) and external assembly (2); Described et al. Ke assembly (1) comprises blood protein sensor (11), data processing module (12), the first wireless communication module (13); Described blood protein sensor (11) comprises albumen trapping layer (111), binding signal inductive layer (112), heating module (113), refrigeration module (114), containment vessel (115); Described albumen trapping layer (111) sticks on binding signal inductive layer (112), described containment vessel (115) covers on described albumen trapping layer (111) for described albumen trapping layer (111) and blood separating being opened, described heating module (113) for by the transient heating of described albumen sensor (11) to more than 56 DEG C, described refrigeration module (114) is for being reduced to physiological temp instantaneously by the temperature of the described albumen sensor (11) of having heated; Described data processing module (12) comprises input interface (121), microprocessor (122), output interface (123), reactor (124); Described input interface (121) receives electrochemical signals that described blood protein sensor (11) exports and inputs described microprocessor (122) after it is converted into digital signal, is uploaded to described external assembly (2) after described microprocessor (122) carries out protocol conversion to digital signal by described output interface (123) via described first wireless communication module (13); Described external assembly (2) comprises data receiver (21), and described data receiver (21) comprises controller (211), display (212), siren (213), the second wireless communication module (214); Described controller (211) receives and analyzes the protein signal that described et al. Ke assembly (1) uploads, afterwards Protein Information is sent to the upper display of described display (212), the analysis programme of described controller (211) arranges a threshold value, when this threshold value of horizontal exceeding of albumen, described controller (211) sends instruction to described siren (213), described siren (213) gives the alarm, and notifies that wearer notes the danger of cancer return; The control command of described controller (211) passes on the described reactor (124) in described et al. Ke assembly (1) by described second wireless communication module (214), and described reactor (124) controls the unlatching of described containment vessel (115) or closedown, the startup of the described heating module of control (113) or dormancy, the startup of the described refrigeration module of control (114) or dormancy.
2. smart machine according to claim 1, it is characterized in that, described external assembly (2) also comprises intelligent mobile terminal equipment (22), described data receiver (21) also comprises the 3rd wireless communication module (215), and Protein Information is sent in described intelligent mobile terminal equipment (22) by described 3rd wireless communication module (215) by described controller (211).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520501151.5U CN204813901U (en) | 2015-07-12 | 2015-07-12 | A smart machine for monitoring of cancer recurring real time kinematic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520501151.5U CN204813901U (en) | 2015-07-12 | 2015-07-12 | A smart machine for monitoring of cancer recurring real time kinematic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204813901U true CN204813901U (en) | 2015-12-02 |
Family
ID=54671551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520501151.5U Withdrawn - After Issue CN204813901U (en) | 2015-07-12 | 2015-07-12 | A smart machine for monitoring of cancer recurring real time kinematic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204813901U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104970806A (en) * | 2015-07-12 | 2015-10-14 | 北京泱深生物信息技术有限公司 | Smart device used for cancer relapse real-time dynamic monitoring |
-
2015
- 2015-07-12 CN CN201520501151.5U patent/CN204813901U/en not_active Withdrawn - After Issue
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104970806A (en) * | 2015-07-12 | 2015-10-14 | 北京泱深生物信息技术有限公司 | Smart device used for cancer relapse real-time dynamic monitoring |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Wearable Internet of Things enabled precision livestock farming in smart farms: A review of technical solutions for precise perception, biocompatibility, and sustainability monitoring | |
| Lai et al. | A survey of body sensor networks | |
| US20200092681A1 (en) | Geolocation bracelet, system, and methods | |
| CN107193382B (en) | Smart wearable devices and methods for automatically utilizing sensors to configure capabilities | |
| CN105208933B (en) | Multiple sensors for the health for monitoring animal | |
| CN102043894B (en) | Physiological data monitoring system and method | |
| Jin et al. | Predicting cardiovascular disease from real-time electrocardiographic monitoring: An adaptive machine learning approach on a cell phone | |
| CN105210070A (en) | Veterinarian user interface for monitoring health and wellness of an animal | |
| CN103971157B (en) | Implantable passive ultra-high frequency RFID temperature sensing tag and its cognitive method for animal-breeding | |
| CN205994491U (en) | A kind of remote detecting system of health sign Index | |
| CN105939654A (en) | Paired thermometer temperature determination | |
| CN205433706U (en) | Noninvasive glucose monitoring based on finger detects | |
| CN203480551U (en) | Hospital clinic information system based on the internet of things | |
| CN206711176U (en) | A kind of cloud attendance recorder with gate function | |
| CN117063243A (en) | Machine learning for improving artificial intelligence algorithm iterations | |
| CN204813901U (en) | A smart machine for monitoring of cancer recurring real time kinematic | |
| CN204315032U (en) | A kind of intelligent baby-monitoring device | |
| Maske et al. | Implementation of BIOBOT System for COVID Patient and Caretakers Assistant Using IOT | |
| Prakashan et al. | Transformation of health care system using internet of things in villages | |
| CN104970806A (en) | Smart device used for cancer relapse real-time dynamic monitoring | |
| KR20090011069A (en) | Cow healthcare system using sensor and gps | |
| CN109079807A (en) | A kind of health robot | |
| CN110488770A (en) | A kind of hospital ward monitoring data acquisition system | |
| CN104939843A (en) | Implanted cancer relapse real-time monitoring system | |
| CN204229469U (en) | A kind of endowment of the wisdom based on cloud platform information equipment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| AV01 | Patent right actively abandoned |
Granted publication date: 20151202 Effective date of abandoning: 20170804 |
|
| AV01 | Patent right actively abandoned |